Intelligence and Neurodevelopmental Disorders After Prenatal Exposure to General Anaesthesia

NCT ID: NCT06633406

Last Updated: 2026-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

192 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-14

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Every year in the European Union, thousands of babies are exposed to anaesthesia before they are born because their mothers need surgery during pregnancy. While these surgeries are necessary, there is a concern that the anaesthesia might affect the baby's brain development. However, there isn't enough research to know for sure how this exposure might impact the child's intelligence or behavior later in life.

The goal of this cohort study is to compare the intelligence and neurodevelopmental outcome of children prenatally exposed to general anaesthesia for maternal abdominal surgery with those of unexposed children and with those of children prenatally exposed to maternal inflammation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Anaesthesia During Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prenatal Anaesthesia Exposure

Children exposed in utero to maternal general anaesthesia to allow laparoscopy or laparotomy for appendicectomy, adnexal pathology, cholecystectomy or for diagnostic procedures to rule out intra-abdominal pathology

Age-appropriate Wechsler Intelligence Test

Intervention Type OTHER

2.5-6 years: Wechsler Preschool and Primary Scale of Intelligence for children (WPPSI IV)

7-16 years: Wechsler Intelligence Scale for Children (WISC V)

\>17 years: Wechsler Adult Intelligence Scale (WAIS IV)

Disruptive Behavior Disorders Rating Scale

Intervention Type OTHER

Dutch version of the Disruptive Behavior Disorders Rating Scale

Social Responsiveness Scale

Intervention Type OTHER

3-18 years: social responsiveness scale 2 (SRS-2)

\>19 years: Social Responsiveness Scale - Adult version (SRS-A)

No Prenatal Anaesthesia Exposure

Children not exposed to general anaesthesia for non-obstetric or obstetric (e.g. cesarean section) surgery in utero

Age-appropriate Wechsler Intelligence Test

Intervention Type OTHER

2.5-6 years: Wechsler Preschool and Primary Scale of Intelligence for children (WPPSI IV)

7-16 years: Wechsler Intelligence Scale for Children (WISC V)

\>17 years: Wechsler Adult Intelligence Scale (WAIS IV)

Disruptive Behavior Disorders Rating Scale

Intervention Type OTHER

Dutch version of the Disruptive Behavior Disorders Rating Scale

Social Responsiveness Scale

Intervention Type OTHER

3-18 years: social responsiveness scale 2 (SRS-2)

\>19 years: Social Responsiveness Scale - Adult version (SRS-A)

Prenatal exposure to maternal inflammation

Children prenatally exposed to maternal inflammation, specifically those born to mothers with inflammatory bowel disease (IBD)

Age-appropriate Wechsler Intelligence Test

Intervention Type OTHER

2.5-6 years: Wechsler Preschool and Primary Scale of Intelligence for children (WPPSI IV)

7-16 years: Wechsler Intelligence Scale for Children (WISC V)

\>17 years: Wechsler Adult Intelligence Scale (WAIS IV)

Disruptive Behavior Disorders Rating Scale

Intervention Type OTHER

Dutch version of the Disruptive Behavior Disorders Rating Scale

Social Responsiveness Scale

Intervention Type OTHER

3-18 years: social responsiveness scale 2 (SRS-2)

\>19 years: Social Responsiveness Scale - Adult version (SRS-A)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Age-appropriate Wechsler Intelligence Test

2.5-6 years: Wechsler Preschool and Primary Scale of Intelligence for children (WPPSI IV)

7-16 years: Wechsler Intelligence Scale for Children (WISC V)

\>17 years: Wechsler Adult Intelligence Scale (WAIS IV)

Intervention Type OTHER

Disruptive Behavior Disorders Rating Scale

Dutch version of the Disruptive Behavior Disorders Rating Scale

Intervention Type OTHER

Social Responsiveness Scale

3-18 years: social responsiveness scale 2 (SRS-2)

\>19 years: Social Responsiveness Scale - Adult version (SRS-A)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Prenatal anaesthesia exposure: Children exposed in utero to maternal general anaesthesia to allow laparoscopy or laparotomy for appendicectomy, adnexal pathology, cholecystectomy or for diagnostic procedures to rule out intra-abdominal pathology
* No prenatal anaesthesia exposure: Children not exposed to general anaesthesia for non-obstetric or obstetric (e.g. cesarean section) surgery in utero
* Children exposed to inflammation: Children born to mothers diagnosed with inflammatory bowel disease (IBD) who had a flare-up during pregnancy without being exposed to general anaesthesia for non-obstetric or obstetric (e.g. cesarean section) surgery in utero.
* Children born in 2000-2023
* (Parental) informed consent

Exclusion Criteria

* Children whose mothers underwent obstetric surgery or foetal surgery/interventions during the same pregnancy.
* No Dutch-speaking children
* Diagnosis of severe disability of genetic origin (e.g., Fragil X, Down syndrome,…), history of head trauma, major congenital birth defects
Minimum Eligible Age

2 Years

Maximum Eligible Age

27 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitaire Ziekenhuizen KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sarah Devroe, MD, Phd

Role: PRINCIPAL_INVESTIGATOR

UZ Leuven

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Imeldaziekenhuis

Bonheiden, Antwerpen, Belgium

Site Status

UZ Leuven

Leuven, Vlaams-Brabant, Belgium

Site Status

AZ Delta

Roeselare, West-Flanders, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S68647

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.